{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Steroid&page=21", "query": { "intervention": "Steroid", "page": 21 }, "page_size": 10 }, "pagination": { "page": 21, "page_size": 10, "total_count": 6274, "total_pages": 628, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Steroid&page=22&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Steroid&page=20&page_size=10" }, "source": "remote", "last_synced_at": "2026-11-06T13:34:25.832Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00806728", "title": "Study of MEDI-507 in With Steroid-Resistant Acute Graft-Versus-Host Disease", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Cancer", "Graft-Versus-Host Disease" ], "interventions": [ { "name": "MEDI-507", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "MedImmune LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 17, "start_date": "1998-05", "completion_date": "1998-12", "has_results": false, "last_update_posted_date": "2008-12-11", "last_synced_at": "2026-11-06T13:34:25.832Z", "location_count": 10, "location_summary": "Duarte, California • Denver, Colorado • Ann Arbor, Michigan + 7 more", "locations": [ { "city": "Duarte", "state": "California" }, { "city": "Denver", "state": "Colorado" }, { "city": "Ann Arbor", "state": "Michigan" }, { "city": "St Louis", "state": "Missouri" }, { "city": "Omaha", "state": "Nebraska" } ], "official_url": "https://clinicaltrials.gov/study/NCT00806728" }, { "nct_id": "NCT00182871", "title": "Testosterone Effects on Bone and Frailty", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Aging", "Frailty", "Osteoporosis" ], "interventions": [ { "name": "testosterone", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "National Institute on Aging (NIA)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "60 Years", "maximum_age": null, "sex": "MALE", "summary": "60 Years and older · Male only" }, "enrollment_count": 140, "start_date": "2001-11", "completion_date": "2007-07", "has_results": false, "last_update_posted_date": "2009-10-30", "last_synced_at": "2026-11-06T13:34:25.832Z", "location_count": 1, "location_summary": "Farmington, Connecticut", "locations": [ { "city": "Farmington", "state": "Connecticut" } ], "official_url": "https://clinicaltrials.gov/study/NCT00182871" }, { "nct_id": "NCT07436793", "title": "Progestins for the Treatment of Endometrial Cancer or Precancers of the Uterus Before Surgery, The Pro-Window Trial", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Endometrial Endometrioid Adenocarcinoma", "Endometrial Hyperplasia" ], "interventions": [ { "name": "Biopsy Procedure", "type": "PROCEDURE" }, { "name": "Curettage Procedure", "type": "PROCEDURE" }, { "name": "Hysterectomy", "type": "PROCEDURE" }, { "name": "Megestrol Acetate", "type": "DRUG" }, { "name": "Progesterone Only Hormone Replacement Therapy", "type": "DRUG" } ], "intervention_types": [ "PROCEDURE", "DRUG" ], "sponsor": "New Mexico Cancer Research Alliance", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "FEMALE", "summary": "18 Years and older · Female only" }, "enrollment_count": 140, "start_date": "2026-06-15", "completion_date": "2031-06-30", "has_results": false, "last_update_posted_date": "2026-07-02", "last_synced_at": "2026-11-06T13:34:25.832Z", "location_count": 4, "location_summary": "Iowa City, Iowa • Albuquerque, New Mexico • Salt Lake City, Utah + 1 more", "locations": [ { "city": "Iowa City", "state": "Iowa" }, { "city": "Albuquerque", "state": "New Mexico" }, { "city": "Salt Lake City", "state": "Utah" }, { "city": "Charlottesville", "state": "Virginia" } ], "official_url": "https://clinicaltrials.gov/study/NCT07436793" }, { "nct_id": "NCT01425099", "title": "Drug Interaction Study Between Dolutegravir and Prednisone", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Infection, Human Immunodeficiency Virus" ], "interventions": [ { "name": "Dolutegravir", "type": "DRUG" }, { "name": "Prednisone", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "ViiV Healthcare", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 12, "start_date": "2011-09", "completion_date": "2011-10", "has_results": false, "last_update_posted_date": "2011-11-07", "last_synced_at": "2026-11-06T13:34:25.832Z", "location_count": 1, "location_summary": "Buffalo, New York", "locations": [ { "city": "Buffalo", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT01425099" }, { "nct_id": "NCT01026363", "title": "hCAP18 Levels and Vitamin D Deficiency in Chronic Kidney Disease", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Chronic Kidney Disease", "Vitamin D Deficiency" ], "interventions": [ { "name": "Ergocalciferol", "type": "DRUG" }, { "name": "Calcitriol", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Massachusetts General Hospital", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 0, "start_date": "2009-12", "completion_date": "2014-12", "has_results": false, "last_update_posted_date": "2015-09-23", "last_synced_at": "2026-11-06T13:34:25.832Z", "location_count": 1, "location_summary": "Cambridge, Massachusetts", "locations": [ { "city": "Cambridge", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT01026363" }, { "nct_id": "NCT05560399", "title": "A Study of Iberdomide (CC-220) in Combination With Elotuzumab and Dexamethasone for Relapsed/Refractory Multiple Myeloma", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "EARLY_PHASE1" ], "conditions": [ "Multiple Myeloma" ], "interventions": [ { "name": "Iberdomide", "type": "DRUG" }, { "name": "Elotuzumab", "type": "DRUG" }, { "name": "Dexamethasone", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Icahn School of Medicine at Mount Sinai", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 7, "start_date": "2023-02-06", "completion_date": "2026-12", "has_results": false, "last_update_posted_date": "2026-01-02", "last_synced_at": "2026-11-06T13:34:25.832Z", "location_count": 1, "location_summary": "New York, New York", "locations": [ { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT05560399" }, { "nct_id": "NCT02122198", "title": "Vascular Mechanisms for the Effects of Loss of Ovarian Hormone Function on Cognition in Women", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Cognitive Impairment", "Executive Dysfunction", "Endothelial Dysfunction", "Cardiovascular Disease" ], "interventions": [ { "name": "Leuprolide acetate", "type": "DRUG" }, { "name": "Estradiol", "type": "DRUG" }, { "name": "Medroxyprogesterone", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Colorado, Denver", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "40 Years", "maximum_age": "60 Years", "sex": "FEMALE", "summary": "40 Years to 60 Years · Female only" }, "enrollment_count": 17, "start_date": "2014-09-08", "completion_date": "2017-09-15", "has_results": true, "last_update_posted_date": "2022-01-10", "last_synced_at": "2026-11-06T13:34:25.832Z", "location_count": 2, "location_summary": "Aurora, Colorado • Boulder, Colorado", "locations": [ { "city": "Aurora", "state": "Colorado" }, { "city": "Boulder", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT02122198" }, { "nct_id": "NCT00030914", "title": "Medroxyprogesterone Compared With Venlafaxine in Treating Hot Flashes in Women", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Hot Flashes" ], "interventions": [ { "name": "medroxyprogesterone", "type": "DRUG" }, { "name": "venlafaxine", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Alliance for Clinical Trials in Oncology", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "FEMALE", "summary": "18 Years and older · Female only" }, "enrollment_count": 227, "start_date": "2002-04", "completion_date": "2006-09", "has_results": false, "last_update_posted_date": "2016-07-13", "last_synced_at": "2026-11-06T13:34:25.832Z", "location_count": 22, "location_summary": "Scottsdale, Arizona • Jacksonville, Florida • Honolulu, Hawaii + 19 more", "locations": [ { "city": "Scottsdale", "state": "Arizona" }, { "city": "Jacksonville", "state": "Florida" }, { "city": "Honolulu", "state": "Hawaii" }, { "city": "Peoria", "state": "Illinois" }, { "city": "Urbana", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT00030914" }, { "nct_id": "NCT05050916", "title": "The Investigation of Vitamin D and Menstrual Cycles Trial, the inVitD Trial: A Phase II Clinical Trial", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Reproductive Issues" ], "interventions": [ { "name": "Vitamin D", "type": "DIETARY_SUPPLEMENT" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "DIETARY_SUPPLEMENT", "OTHER" ], "sponsor": "National Institute of Environmental Health Sciences (NIEHS)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "19 Years", "maximum_age": "40 Years", "sex": "FEMALE", "summary": "19 Years to 40 Years · Female only" }, "enrollment_count": 998, "start_date": "2023-03-17", "completion_date": "2024-06-27", "has_results": false, "last_update_posted_date": "2026-11-05", "last_synced_at": "2026-11-06T13:34:25.832Z", "location_count": 2, "location_summary": "Detroit, Michigan • Research Triangle Park, North Carolina", "locations": [ { "city": "Detroit", "state": "Michigan" }, { "city": "Research Triangle Park", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT05050916" }, { "nct_id": "NCT06097364", "title": "A Trial to Learn if Odronextamab Combined With Chemotherapy is Safe and Well-Tolerated and How Well it Works Compared to Rituximab Combined With Chemotherapy for Adult Participants With Follicular Lymphoma", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Follicular Lymphoma (FL)" ], "interventions": [ { "name": "Odronextamab", "type": "DRUG" }, { "name": "Rituximab", "type": "DRUG" }, { "name": "Cyclophosphamide", "type": "DRUG" }, { "name": "Doxorubicin", "type": "DRUG" }, { "name": "Vincristine", "type": "DRUG" }, { "name": "Prednisone/Prenisolone", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Regeneron Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 733, "start_date": "2023-11-14", "completion_date": "2029-07-29", "has_results": false, "last_update_posted_date": "2026-02-06", "last_synced_at": "2026-11-06T13:34:25.832Z", "location_count": 9, "location_summary": "Plantation, Florida • Noblesville, Indiana • Wichita, Kansas + 6 more", "locations": [ { "city": "Plantation", "state": "Florida" }, { "city": "Noblesville", "state": "Indiana" }, { "city": "Wichita", "state": "Kansas" }, { "city": "Lexington", "state": "Kentucky" }, { "city": "Detroit", "state": "Michigan" } ], "official_url": "https://clinicaltrials.gov/study/NCT06097364" } ] }